CNP
Basic information
Region (hg38): 17:41966763-41977740
Links
Phenotypes
GenCC
Source:
- leukodystrophy, hypomyelinating, 20 (Limited), mode of inheritance: AR
- leukodystrophy, hypomyelinating, 20 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Leukodystrophy, hypomyelinating, 20 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Dermatologic; Neurologic | 32128616 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (45 variants)
- Myopia_2,_autosomal_dominant (6 variants)
- not_provided (5 variants)
- Leukodystrophy,_hypomyelinating,_20 (3 variants)
- CNP-related_disorder (2 variants)
- Marfanoid_habitus_and_intellectual_disability (1 variants)
- Achondroplasia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CNP gene is commonly pathogenic or not. These statistics are base on transcript: NM_000033133.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 45 | 52 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 4 | 0 | 45 | 7 | 1 |
Highest pathogenic variant AF is 0.0000065684
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CNP | protein_coding | protein_coding | ENST00000393892 | 4 | 10991 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.984 | 0.0159 | 124772 | 0 | 5 | 124777 | 0.0000200 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.43 | 161 | 274 | 0.587 | 0.0000186 | 2705 |
Missense in Polyphen | 38 | 86.704 | 0.43827 | 820 | ||
Synonymous | 0.900 | 112 | 125 | 0.897 | 0.00000866 | 877 |
Loss of Function | 3.59 | 1 | 17.0 | 0.0589 | 0.00000103 | 188 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000293 | 0.0000293 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000270 | 0.0000265 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000166 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: May participate in RNA metabolism in the myelinating cell, CNP is the third most abundant protein in central nervous system myelin. {ECO:0000250}.;
- Pathway
- Glial Cell Differentiation;MECP2 and Associated Rett Syndrome
(Consensus)
Recessive Scores
- pRec
- 0.224
Intolerance Scores
- loftool
- 0.292
- rvis_EVS
- -0.42
- rvis_percentile_EVS
- 25.56
Haploinsufficiency Scores
- pHI
- 0.193
- hipred
- Y
- hipred_score
- 0.673
- ghis
- 0.532
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.389
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cnp
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- microtubule cytoskeleton organization;chemical synaptic transmission;axonogenesis;aging;adult locomotory behavior;cyclic nucleotide catabolic process;response to toxic substance;substantia nigra development;forebrain development;response to lipopolysaccharide;regulation of mitochondrial membrane permeability;oligodendrocyte differentiation
- Cellular component
- extracellular space;nucleus;nucleoplasm;cytoplasm;mitochondrial outer membrane;mitochondrial inner membrane;cytosol;plasma membrane;microvillus;membrane;pseudopodium;myelin sheath abaxonal region;myelin sheath adaxonal region;melanosome;perinuclear region of cytoplasm;extracellular exosome
- Molecular function
- RNA binding;2',3'-cyclic-nucleotide 3'-phosphodiesterase activity;cyclic nucleotide binding